Growing community of inventors

Frankfurt am Main, Germany

Christoph Pöverlein

Average Co-Inventor Count = 8.40

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Christoph PöverleinHeiner Glombik (4 patents)Christoph PöverleinKurt Ritter (4 patents)Christoph PöverleinLothar Schwink (4 patents)Christoph PöverleinChristian Buning (4 patents)Christoph PöverleinNis Halland (4 patents)Christoph PöverleinMatthias Lohmann (4 patents)Christoph PöverleinDieter Kadereit (3 patents)Christoph PöverleinMatthias Gossel (3 patents)Christoph PöverleinChristoph Pöverlein (4 patents)Heiner GlombikHeiner Glombik (75 patents)Kurt RitterKurt Ritter (44 patents)Lothar SchwinkLothar Schwink (34 patents)Christian BuningChristian Buning (25 patents)Nis HallandNis Halland (14 patents)Matthias LohmannMatthias Lohmann (5 patents)Dieter KadereitDieter Kadereit (57 patents)Matthias GosselMatthias Gossel (46 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Sanofi (4 from 1,456 patents)


4 patents:

1. 10392366 - Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

2. 9908868 - Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

3. 9896434 - Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

4. 9758520 - Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/8/2026
Loading…